Abstract LB-107: Targeting CDK7-dependent transcriptional addiction with novel, orally available small molecule inhibitor shows efficacy in pancreatic cancer models
Thode, Trason, Li, Zhaoliang, Weston, Alexis, Soldi, Raffaella, Kaadige, Mohan Rao, Vankayalapti, Hariprasad, Sharma, Sunil
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Published in Cancer research (Chicago, Ill.) (01.07.2019)
Get full text
Journal Article
Abstract 5221: Development of TGN-1076, a selective and reversible small molecule inhibitor of CDK7
Thode, Trason, Li, Zhaoliang, Weston, Alexis, Dana, Srikanta, Ampanattu, Sherin Daniel, Soldi, Raffaella, Kaadige, Mohan Rao, Vankayalapti, Hariprasad, Chung, Vincent, Chao, Joseph, Von Hoff, Daniel D, Sharma, Sunil
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Published in Cancer research (Chicago, Ill.) (15.08.2020)
Get full text
Journal Article
Abstract 607: Development of a novel, selective, and potent inhibitor of RON kinase
Kaadige, Mohan Rao, Thode, Trason, Fornetti, Jaime, Weston, Alexis, Ng, Serina, Ghosh-Halder, Tithi, Bargenquast, Taylor, Durbin, Brian, Kasibhatla, Srinivas, Soldi, Raffaella, Welm, Alana, Sharma, Sunil
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Published in Cancer research (Chicago, Ill.) (22.03.2024)
Get full text
Journal Article